Board Directors

Nick is an experienced CEO with over 20 years’ experience in public listed and private companies operating internationally across the life sciences, healthcare diagnostic and biotechnology industries.

Prior to joining Biofortuna, Nick was CEO of Source BioScience plc, the Main Market-listed healthcare diagnostics and genomic services business, where he established operations in the US and Europe, growing revenues five fold.

Nick holds a PhD in Mycology and is a Chartered Accountant, qualifying with KPMG.

Nick Ash / CEO
Nick is an experienced Chief Operating Officer in the life sciences and healthcare diagnostic sectors.

Prior to joining Biofortuna, Nick was COO of Source BioScience plc, expanding the laboratory infrastructure from a single site in the UK to ten facilities worldwide. Before Source BioScience, Nick worked for over ten years in complex genetics and genomics, initially at Oxford University and then for the MRC at the Wellcome Trust Sanger Centre, subsequently Geneservice.

Nick qualified as a microbiologist and worked in the NHS, completing a PhD on the molecular methods used to characterise outbreaks of bacterial meningitis.

Nick Leaves / COO
Mark is a serial supporter of growth companies with a wealth of experience of start-up and early stage businesses. He is a director of a number of health and life science companies, whose technologies range from oncology therapeutic development through to medical devices for a range of applications including the management of metabolic disease.
Mark Hurley / Chairman

FIND OUT MORE

Great collaborations start with a conversation. To discuss your next project, fill in the form below

Contact us